NCT05689775

Brief Summary

Non-randomized study of robot-assisted perineal reconstruction with rectus abdominis muscle flap in patients operated with abdominoperineal resection for irradiated locally advanced rectal or anal cancer. Operative time, complications, wound healing, pre- and postoperatively abdominal wall strength and patient related outcomes including sexual health will be registered.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Sep 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Sep 2022Dec 2026

Study Start

First participant enrolled

September 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 19, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

January 19, 2023

Status Verified

January 1, 2023

Enrollment Period

2.3 years

First QC Date

November 23, 2022

Last Update Submit

January 10, 2023

Conditions

Keywords

Rectus abdominis muscle flapReconstructionPerineum

Outcome Measures

Primary Outcomes (1)

  • Perineal wound healing

    Perineal wound healing at 3 months. Perineal wound has completely healed at clinical control 3 months postoperatively without need for further follow-up of the perineal wound. Any perineal complications are noted. * superficial wound infection * deep wound infection * minor wound dehiscence * major wound dehiscence * partial flap loss * total flap loss * perineal hernia * enterocutaneous fistula * stricture in neovagina * perineal wound dehiscence not related to flap * other complications

    3 months

Secondary Outcomes (5)

  • Early postoperative complications

    Within 30 days postoperatively

  • Late postoperative complications

    Later than 30 days postoperatively

  • Quality of life - general

    Preoperatively. 3 months and 12 months postoperatively.

  • Quality of life - sexual

    Preoperatively. 3 months and 12 months postoperatively.

  • Abdominal wall strength

    Preoperatively. 3 months and 12 months postoperatively.

Study Arms (1)

Patients

Patients over 18 years of age operated for locally advanced anal or rectal cancer with robot-assisted abdomino-perinal resection and robot-assisted reconstruction of pelvic floor and/or vagina with vertical rectus abdomínis muscle flap.

Procedure: Reconstruction with robot-assisted rectus abdominis muscle flap

Interventions

Reconstruction of perineum and/or vagina with robot-assisted rectus abdominis muscle flap.

Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with rectal or anal cancer who are scheduled for robot-assisted abdominoperineal resection who need reconstruction of pelvic floor and/or vagina with rectus abdomens muscle flap.

You may qualify if:

  • patients with rectal or anal cancer
  • scheduled for robot-assisted abdominoperineal resection
  • reconstruction of pelvic floor and/or vagina with rectus abdominis muscle flap

You may not qualify if:

  • patients not eligible for robot-assisted procedure
  • rectus abdominis muscle not available for harvest
  • the expected wound defect is not suitable for reconstruction with rectus abdominis muscle flap

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital, Radiumhospitalet

Oslo, 0424, Norway

RECRUITING

MeSH Terms

Conditions

Wounds and InjuriesPostoperative ComplicationsRectal Neoplasms

Interventions

Plastic Surgery Procedures

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Lars Frich, MD, PhD

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lars Frich, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

November 23, 2022

First Posted

January 19, 2023

Study Start

September 1, 2022

Primary Completion

December 31, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

January 19, 2023

Record last verified: 2023-01

Locations